ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Washington University in St. Louis at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Washington University in St. Louis takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans gastrointestinal and genitourinary cancers, alongside brain tumours and biomarkers. It examines treatments for biliary tract, bladder and kidney cancers, and whether changes in a blood marker track glioblastoma activity.

OrganizationESMO 2026 Attendance
University & institute
Private research university in St. Louis, Missouri, with a school of medicine and a cancer centre.
Poster
Fri Oct 23
15:15–16:00
LDH kinetics as a biomarker of disease activity in glioblastoma treated with porphyrin metabolite activation (PoMA)
Friday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Washington University in St. Louis

Tell us what you sell and we’ll find the people at Washington University in St. Louis most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction